PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.06%
Some net income increase while CRK is negative at -152.21%. John Neff would see a short-term edge over the struggling competitor.
-4.24%
Negative yoy D&A while CRK is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
69.83%
Some yoy growth while CRK is negative at -51.08%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
280.60%
Well above CRK's 124.66% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
280.60%
Growth well above CRK's 136.42%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
775.00%
Well above CRK's 37.77%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
80.98%
Operating cash flow growth below 50% of CRK's 861.23%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
2.26%
Lower CapEx growth vs. CRK's 26.82%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-487.50%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
68.42%
Purchases growth of 68.42% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-2.26%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
4.92%
We have some outflow growth while CRK is negative at -85.89%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
13.17%
We have mild expansions while CRK is negative at -448.93%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.